Morgan Stanley’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $575K | Buy |
113,722
+51,246
| +82% | +$259K | ﹤0.01% | 5402 |
|
|
2025
Q1 | $353K | Sell |
62,476
-12,799
| -17% | -$72.3K | ﹤0.01% | 5488 |
|
|
2024
Q4 | $653K | Buy |
75,275
+10,842
| +17% | +$94.1K | ﹤0.01% | 5309 |
|
|
2024
Q3 | $447K | Buy |
64,433
+44,975
| +231% | +$312K | ﹤0.01% | 5457 |
|
|
2024
Q2 | $121K | Buy |
+19,458
| New | +$121K | ﹤0.01% | 5897 |
|
|
2023
Q1 | – | Sell |
-92
| Closed | -$165 | – | 7724 |
|
|
2022
Q4 | $165 | Sell |
92
-5,188
| -98% | -$9.31K | ﹤0.01% | 7658 |
|
|
2022
Q3 | $17K | Buy |
5,280
+659
| +14% | +$2.12K | ﹤0.01% | 6851 |
|
|
2022
Q2 | $15K | Sell |
4,621
-30
| -0.6% | -$97 | ﹤0.01% | 7091 |
|
|
2022
Q1 | $24K | Sell |
4,651
-71
| -2% | -$366 | ﹤0.01% | 7068 |
|
|
2021
Q4 | $36K | Buy |
+4,722
| New | +$36K | ﹤0.01% | 6961 |
|